XML 30 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following is a reconciliation of the numerator and denominator of basic and diluted earnings per share for the three and nine months ended September 30, 2015 and 2014:
 
(In 000s, except per share data)
 
Three Months Ended
  
Nine Months Ended
 
 
 
September 30,
  
September 30,
  
September 30,
  
September 30,
 
 
 
2015
  
2014
  
2015
  
2014
 
Numerator:
        
Net income (loss) attributable to Healthways, Inc. - numerator for basic earnings (loss) per share
 
$
(9,026
)  
$
1,973
 
 
$
(11,520
)
 
$
(8,139
)
 
                
Denominator:
                
Shares used for basic income (loss) per share
  
35,939
   
35,351
   
35,756
   
35,263
 
Effect of dilutive securities outstanding:
                
Non-qualified stock options  (1)
  
   
770
   
   
 
Restricted stock units (1)
  
   
318
   
   
 
Performance-based stock units (1)
  
   34   
   
 
CareFirst Warrants  (1)
  
   
4
   
   
 
Shares used for diluted income per share (1)
 
$
35,939
  
$
36,477
  
$
35,756
  
$
35,263
 
 
                
Earnings (loss) per share:
                
Basic
 
$
(0.25
)  
$
0.06
 
 
$
(0.32
)
 
$
(0.23
)
Diluted (1)
 
$
(0.25
)  
$
0.05
 
 
$
(0.32
)
 
$
(0.23
)
 
                
Dilutive securities outstanding not included in the computation of loss per share because their effect is antidilutive:
                
Non-qualified stock options
  
1,770
   
1,131
   
1,284
   
2,153
 
Restricted stock units
  
662
   
54
   
580
   
390
 
Performance-based stock units
  
   2   
   16 
   Market stock units  8   
   3   
 
Warrants related to Cash Convertible Notes
  
7,707
   
7,707
   
7,707
   
7,707
 
CareFirst Convertible Note
  
892
   
892
   
892
   
892
 
CareFirst Warrants
  
432
   
83
   
223
   
86
 
 
(1) The impact of potentially dilutive securities for the three and nine months ended September 30, 2015 and the nine months ended September 30, 2014 was not considered because the effect would be anti-dilutive in each of those periods.